ACCESS ASIA Spring BD Salon & Reception 2026
Global biotech collaboration is undergoing structural change. China-origin innovation is now embedded in global pipelines — not as a regional complement, but as a strategic driver.
On April 27, 2026 in Shanghai, ACCESS ASIA Spring BD Salon & Reception 2026 will convene senior decision-makers focused on cross-border biotech partnerships.
Hosted by ACCESS ASIA and YAFO Capital, the gathering is designed as a curated, high-level platform dedicated to strategic dialogue and transaction execution, reflecting six consecutive years of cross-border convening experience.
Event Details
Date: April 27, 2026
Location: YAFO Office, Shanghai
Format: 1-on-1 meetings and Cocktail Reception
Registration
- ACCESS ASIA Bio Membership: Registration is now open.
- Please contact: ACCESS ASIA Bio (AAB) Team | accessasiabio@gmail.com
- Members are pre-confirmed to be an event attendee. How to become a member
- For interested event-attendees: Registration is open now; registrations will be reviewed in April. Learn more
Agenda
Agenda updates are available on the official event page. Agenda Page Link
Who Will Be in the Room
Participants include senior representatives from multinational pharma, global biotech, and leading investment institutions, including:
- Asian innovators seeking global licensing and strategic partners
- Global and regional buyers — including multinational pharma, biopharma companies, and venture capital investors
- Global innovators pursuing strategic entry and partnerships in Asia
- Leading China-based CRO/CDMO supporting global development and manufacturing execution
Previous Participants
Why It Matters Now
Global biopharma collaboration is undergoing structural change.
As BD expands, licensing globalizes, and development accelerates, structured cross-border access becomes strategic infrastructure.
Register and Attend to ACCESS ASIA Spring BD Salon & Reception 2026
Participation is by registration and confirmation.
For inquiries / sponsorship / partnership:
Wendi Xiang | wxiang@yafocapital.com
Become a member of ACCESS ASIA Bio
ACCESS ASIA Bio is an independent, curated cross-border BD ecosystem connecting Asian innovators with global pharmaceutical companies, investors, and strategic partners.
YAFO Capital serves as the founding partner supporting the platform’s development.
Membership is application-based to maintain ecosystem quality, strategic alignment, and senior-level engagement across the network.
Members benefit from:
- Prioritized participation in ACCESS ASIA and affiliated events
- Early access to attendee visibility and structured 1-on-1 partnering
- Enhanced company exposure across ACCESS ASIA communications / Enhanced BD demand exposure across ACCESS Asia communications
- Targeted BD opportunity alerts and ecosystem intelligence updates/ Targeted Asian Asset BD opportunity alerts and ecosystem intelligence updates
- Invitation to closed-door networking and member-only gatherings and more
- Presenting opportunity for premium members
Designed to support disciplined Asia–global integration, ACCESS ASIA Bio provides structured visibility and ongoing engagement beyond a single event.
For inquiries / sponsorship / partnership:
ACCESS ASIA Bio Team | accessasia.bio@gmail.com
Follow us and be updated!
Previous ACCESS ASIA Events
Over the years, ACCESS ASIA has brought together leading companies, investors, and executives shaping the future of biotech.
BioToChina.org 